ArticleOncology letters2020

Inhibiting the Src/STAT3 signaling pathway contributes to the anti-melanoma mechanisms of dioscin.

Yu-Xi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.